BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 31566077)

  • 1. The Skin Cancer Index: quality-of-life outcomes of treatments for nonmelanoma skin cancer.
    Sanchez N; Griggs J; Nanda S; Fayne R; Castillo D; De Bedout V; Meirson D; Nichols A
    J Dermatolog Treat; 2020 Aug; 31(5):491-493. PubMed ID: 31566077
    [No Abstract]   [Full Text] [Related]  

  • 2. Quality-of-life outcomes of treatments for cutaneous basal cell carcinoma and squamous cell carcinoma.
    Chren MM; Sahay AP; Bertenthal DS; Sen S; Landefeld CS
    J Invest Dermatol; 2007 Jun; 127(6):1351-7. PubMed ID: 17301830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin cancer and quality of life: assessment with the Dermatology Life Quality Index.
    Rhee JS; Matthews BA; Neuburg M; Smith TL; Burzynski M; Nattinger AB
    Dermatol Surg; 2004 Apr; 30(4 Pt 1):525-9. PubMed ID: 15056143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mohs appropriate use criteria: retrospectively applied to nonmelanoma skin cancers at a single academic center.
    Chong T; Tristani-Firouzi P; Bowen GM; Hadley ML; Duffy KL
    Dermatol Surg; 2015 Aug; 41(8):889-95. PubMed ID: 26066619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of synchronous and metachronous second nonmelanoma skin cancer when referred for Mohs micrographic surgery.
    Schinstine M; Goldman GD
    J Am Acad Dermatol; 2001 Mar; 44(3):497-9. PubMed ID: 11209121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of a Second Skin Cancer in a Cohort of Patients With Nonmelanoma Skin Cancer -Basal Cell Carcinoma or Squamous Cell Carcinoma-Treated With Mohs Micrographic Surgery: A National Prospective Cohort Study.
    Miñano Medrano R; López Estebaranz JL; Sanmartin-Jiménez O; Garcés JR; Rodríguez-Prieto MA; Vilarrasa-Rull E; de Eusebio-Murillo E; Escutia-Muñoz B; Flórez-Menéndez Á; Artola-Igarza JL; Alfaro-Rubio A; Redondo P; Delgado-Jiménez Y; Sánchez-Schmidt JM; Allende-Markixana I; Alonso-Pacheco ML; García-Bracamonte B; de la Cueva-Dobao P; Navarro-Tejedor R; Ciudad-Blanco C; Carnero-González L; Vázquez-Veiga H; Cano-Martínez N; Ruiz-Salas V; Sánchez-Sambucety P; Botella-Estrada R; González-Sixto B; Martorell-Calatayud A; Gil P; Morales-Gordillo V; Toll-Abelló A; Ocerin-Guerra I; Mayor-Arenal M; Suárez-Fernández R; Sainz-Gaspar L; Descalzo MA; García-Doval I;
    Actas Dermosifiliogr; 2022 May; 113(5):451-458. PubMed ID: 35431059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathologic upgrading of nonmelanoma skin cancer at the time of Mohs micrographic surgery: A prospective review.
    Kyllo RL; Staser KW; Rosman I; Council ML; Hurst EA
    J Am Acad Dermatol; 2019 Aug; 81(2):541-547. PubMed ID: 31230975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation Between Incisional Biopsy Histological Subtype and a Mohs Surgery Specimen for Nonmelanoma Skin Cancer.
    Cortés-Peralta EC; Ocampo-Candiani J; Vázquez-Martínez OT; Gutiérrez-Villarreal IM; Miranda-Maldonado I; Garza-Rodríguez V
    Actas Dermosifiliogr (Engl Ed); 2018; 109(1):47-51. PubMed ID: 29066323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comorbidity scores associated with limited life expectancy in the very elderly with nonmelanoma skin cancer.
    Rogers EM; Connolly KL; Nehal KS; Dusza SW; Rossi AM; Lee E
    J Am Acad Dermatol; 2018 Jun; 78(6):1119-1124. PubMed ID: 29288096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mohs micrographic surgery: a cost analysis.
    Cook J; Zitelli JA
    J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):698-703. PubMed ID: 9810885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curettage prior to Mohs' micrographic surgery for previously biopsied nonmelanoma skin cancers: what are we curetting? Retrospective, prospective, and comparative study.
    Jih MH; Friedman PM; Goldberg LH; Kimyai-Asadi A
    Dermatol Surg; 2005 Jan; 31(1):10-5. PubMed ID: 15720088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory errors leading to nonmelanoma skin cancer recurrence after Mohs micrographic surgery.
    Zabielinski M; Leithauser L; Godsey T; Gloster HM
    Dermatol Surg; 2015 Aug; 41(8):913-6. PubMed ID: 26218725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mohs micrographic surgery vs traditional surgical excision: a cost comparison analysis.
    Bialy TL; Whalen J; Veledar E; Lafreniere D; Spiro J; Chartier T; Chen SC
    Arch Dermatol; 2004 Jun; 140(6):736-42. PubMed ID: 15210467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Creation of a quality of life instrument for nonmelanoma skin cancer patients.
    Rhee JS; Matthews BA; Neuburg M; Burzynski M; Nattinger AB
    Laryngoscope; 2005 Jul; 115(7):1178-85. PubMed ID: 15995503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Tumor Characteristics With Insurance Type Among Patients Undergoing Mohs Micrographic Surgery for Nonmelanoma Skin Cancer.
    Clarke EL; Willenbrink TJ; Shelton M; Naeem A; Custer J; Lundgren AD; Boothe WD; Rathouz PJ; Adamson AS; Fox MC; Jambusaria-Pahlajani A
    JAMA Dermatol; 2022 Aug; 158(8):919-922. PubMed ID: 35648411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of non-melanoma skin cancers of the cutaneous perioral and vermilion lip treated by Mohs micrographic surgery.
    Queen D; Knackstedt T; Polacco MA; Collins LK; Lee K; Samie FH
    J Eur Acad Dermatol Venereol; 2019 Feb; 33(2):305-311. PubMed ID: 30284728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mohs micrographic surgery for digital melanoma and nonmelanoma skin cancers.
    Husain Z; Allawh RM; Hendi A
    Cutis; 2018 May; 101(5):346-352. PubMed ID: 29894522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suggested excisional margins for cutaneous malignant lesions based on Mohs micrographic surgery.
    Schell AE; Russell MA; Park SS
    JAMA Facial Plast Surg; 2013; 15(5):337-43. PubMed ID: 23744451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes in intermediate-risk squamous cell carcinomas treated with Mohs micrographic surgery compared with wide local excision.
    Xiong DD; Beal BT; Varra V; Rodriguez M; Cundall H; Woody NM; Vidimos AT; Koyfman SA; Knackstedt TJ
    J Am Acad Dermatol; 2020 May; 82(5):1195-1204. PubMed ID: 31887322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The skin cancer index: clinical responsiveness and predictors of quality of life.
    Rhee JS; Matthews BA; Neuburg M; Logan BR; Burzynski M; Nattinger AB
    Laryngoscope; 2007 Mar; 117(3):399-405. PubMed ID: 17334300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.